Cite
HARVARD Citation
Rehulka, J. et al. (2022). Anticancer 5‐arylidene‐2‐(4‐hydroxyphenyl)aminothiazol‐4(5H)‐ones as tubulin inhibitors. Archiv der Pharmazie. 355 (12), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rehulka, J. et al. (2022). Anticancer 5‐arylidene‐2‐(4‐hydroxyphenyl)aminothiazol‐4(5H)‐ones as tubulin inhibitors. Archiv der Pharmazie. 355 (12), p. n/a. [Online].